SCHEMBL24867413

SCHEMBL24867413

CC(=O)Nc1nnc(-c2ccncc2)[nH]1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.50
ALDH1A1 P00352 2/20 0.50
GAA P10253 2/20 0.50
HPGD P15428 2/20 0.50
FGFR1 P11362 1/20 0.41
FGFR2 P21802 1/20 0.41
CSNK1A1 P48729 1/20 0.41
CSNK1D P48730 1/20 0.41
CLK2 P49760 1/20 0.41
CSNK1G1 Q9HCP0 1/20 0.41
TSHR P16473 1/20 0.41
ALOX5 P09917 1/20 0.40
LMNA P02545 1/20 0.40
MAPK14 Q16539 2/20 0.39
MAPK13 O15264 1/20 0.39
MAPK12 P53778 1/20 0.39
MAPK11 Q15759 1/20 0.39
PIK3CA P42336 1/20 0.39
PIK3CG P48736 1/20 0.39
EPHX1 P07099 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14960337 0.85 FGFR1 (0.55) KDM4EALDH1A1FGFR1FGFR2TSHR
SCHEMBL24867004 0.83 KDM4E (0.52) KDM4EALDH1A1GAAHPGDTSHR
SCHEMBL15452411 0.82 ALDH1A1 (0.54) KDM4EALDH1A1HPGDLMNAPIK3CA
SCHEMBL24867395 0.79 F2 (0.58) KDM4EALDH1A1EPHX1ADORA3F2
SCHEMBL24867379 0.77 LMNA (0.49) HPGDTSHRLMNAMAPK14ADORA3
SCHEMBL14647244 0.77 KMT2A (0.54) KDM4EALDH1A1GAAHPGDLMNA
SCHEMBL24867597 0.76 PRKACA (0.52) ALDH1A1GAAHPGDMAPK14HSD17B10
SCHEMBL31741174 0.75 KDM4E (0.54) KDM4EALDH1A1GAAHPGDFGFR1
SCHEMBL24867002 0.75 RAB9A (0.44) TSHRLMNAADORA3
SCHEMBL24867414 0.74 LMNA (0.59) KDM4EGAATSHRLMNAMAPK14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230008433-A1 Inhibitors of SARM1 DISARM THERAPEUTICS, INC. 2023-01-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230008433-A1 Inhibitors of SARM1 SARM1, SMN1; SMN2, SARNP KDM4E 3087/4885ALDH1A1 4157/4885GAA 1897/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.